Heart failure & cardiomyopathiesMeta-analysis

Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Acute Myocarditis

JACC Heart FailPublished

  • Systematic review and meta-analysis of observational studies
  • PRISMA
  • PubMed and Embase searched on March 4, 2023

Authors' conclusion

Genetic variants are present in a large proportion of patients with acute myocarditis. The prevalence of genetic variants and the genes involved vary according to age and clinical presentation.

Study context

Population
Patients with acute myocarditis
Participants
586 patients · 8 studies
Comparison
Uncomplicated myocarditis vs Complicated myocarditis, adults vs Complicated myocarditis, children
Outcome
Prevalence of pathogenic or likely pathogenic (P/LP) variants in cardiomyopathy-associated genes

Pooled result

As reported in the abstract

Pooled prevalence of P/LP variants

Pooled prevalence of P/LP variants Uncomplicated myocarditis 4.2% (95% CI 1.8%–7.4%) · Complicated myocarditis, adults 21.9% (95% CI 14.3%–30.5%) · Complicated myocarditis, children 44.5% (95% CI 22.7%–67.4%)

I²

P/LP variants in cardiomyopathy-associated genes reported (89 variants)
85 patients

Further pooled results

OutcomeUncomplicated myocarditisComplicated myocarditis, adultsComplicated myocarditis, children
Gene type of P/LP variants
Desmosomal genes (predominant)64%Not reported in the abstractNot reported in the abstract
Sarcomeric genesNot reported in the abstract58%71%

Original publication

Prevalence of Pathogenic Variants in Cardiomyopathy-Associated Genes in Acute Myocarditis. JACC Heart Fail. Published 3 April 2024. doi:10.1016/j.jchf.2024.02.012

Summarised from the published abstract; every number is checked against it